SQZ Biotechnologies Share Holder Equity 2020-2022 | SQZ

SQZ Biotechnologies share holder equity from 2020 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
SQZ Biotechnologies Annual Share Holder Equity
(Millions of US $)
2021 $124
2020 $127
2019 $59
SQZ Biotechnologies Quarterly Share Holder Equity
(Millions of US $)
2022-06-30 $88
2022-03-31 $105
2021-12-31 $124
2021-09-30 $133
2021-06-30 $153
2021-03-31 $169
2020-12-31 $127
2020-09-30 $70
2020-06-30 $0
2020-03-31 $0
2019-12-31
2019-09-30 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.068B $0.027B
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.984B 9.16
GSK (GSK) United Kingdom $59.709B 7.17
Bio-Rad Laboratories (BIO.B) United States $12.433B 27.47
Biohaven Pharmaceutical Holding (BHVN) United States $10.873B 0.00
QIAGEN (QGEN) Netherlands $9.383B 15.71
Ginkgo Bioworks Holdings (DNA) United States $4.998B 0.00
Arcus Biosciences (RCUS) United States $1.819B 35.51
Myovant Sciences (MYOV) United Kingdom $1.614B 0.00
Emergent Biosolutions (EBS) United States $1.040B 6.03
ADC Therapeutics SA (ADCT) Switzerland $0.376B 0.00
Zymeworks (ZYME) Canada $0.305B 0.00
Enzo Biochem (ENZ) United States $0.105B 0.00
Gelesis Holdings (GLS) United States $0.081B 0.00
Ambrx Biopharma (AMAM) United States $0.041B 0.00